Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2022 Filed Jun 8, 2022 23:48 UTC |
WINSTON ROYChief Medical Officer
|
SaleCommon Stock | 123 | $63.69 | $7,833.87 |
DisclosureSEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 10 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,160 F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.60 to $64.06, inclusive. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:48 UTC |
WINSTON ROYChief Medical Officer
|
SaleCommon Stock | 1,891 | $62.48 | $118,149.68 |
DisclosureSEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 9 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,283 F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.200 to $62.935, inclusive. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:48 UTC |
WINSTON ROYChief Medical Officer
|
SaleCommon Stock | 3,650 | $61.59 | $224,803.50 |
DisclosureSEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 8 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,174 F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.22 to $62.18, inclusive. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:48 UTC |
WINSTON ROYChief Medical Officer
|
SaleCommon Stock | 3,533 | $60.55 | $213,923.15 |
DisclosureSEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 7 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,824 F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.220 to $61.215, inclusive. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:48 UTC |
WINSTON ROYChief Medical Officer
|
SaleCommon Stock | 115 | $63.40 | $7,291.00 |
DisclosureSEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 6 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,357 F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.29 to $64.14, inclusive. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:48 UTC |
WINSTON ROYChief Medical Officer
|
SaleCommon Stock | 1,300 | $62.43 | $81,159.00 |
DisclosureSEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 5 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,472 F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.23 to $62.78, inclusive. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:48 UTC |
WINSTON ROYChief Medical Officer
|
SaleCommon Stock | 2,300 | $61.59 | $141,657.00 |
DisclosureSEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 4 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,772 F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.23 to $62.17, inclusive. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:48 UTC |
WINSTON ROYChief Medical Officer
|
SaleCommon Stock | 2,535 | $60.55 | $153,494.25 |
DisclosureSEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 3 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,072 F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.23 to $61.22, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 3 through 10. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:48 UTC |
WINSTON ROYChief Medical Officer
|
Exercise / conversionCommon Stock | 6,250 | $34.38 | $214,843.75 |
DisclosureSEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 2 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:48 UTC |
WINSTON ROYChief Medical Officer
|
SaleCommon Stock | 2,099 | $61.37 | $128,824.03 |
DisclosureSEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 1 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,357 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:44 UTC |
RIKER LAURENSenior Vice President, Finance
|
SaleCommon Stock | 1,150 | $61.37 | $70,580.10 |
DisclosureSEC source: 0001209191-22-035231 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,002 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:40 UTC |
REINHARDT MAXPresident, Rest of World
|
SaleCommon Stock | 2,817 | $61.37 | $172,890.56 |
DisclosureSEC source: 0001209191-22-035229 · doc4.xml · nonDerivative · entry 1 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,833 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:34 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
SaleCommon Stock | 2,980 | $61.37 | $182,894.52 |
DisclosureSEC source: 0001209191-22-035226 · doc4.xml · nonDerivative · entry 1 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,570 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:39 UTC |
LARANJEIRA CHARLES ANTHONYChief Technical Officer
|
SaleCommon Stock | 2,813 | $61.37 | $172,645.06 |
DisclosureSEC source: 0001209191-22-035228 · doc4.xml · nonDerivative · entry 1 LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,789 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:31 UTC |
McLoughlin DennisChief Customer Officer
|
SaleCommon Stock | 2,140 | $61.37 | $131,340.36 |
DisclosureSEC source: 0001209191-22-035225 · doc4.xml · nonDerivative · entry 1 McLoughlin Dennis · CIK 0001752004 · Chief Customer Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,820 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. F2 · balance_after: Includes 258 and 161 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021 and December 2021, respectively. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:24 UTC |
GAUGLER DARYLChief Operating Officer
|
SaleCommon Stock | 1,106 | $61.37 | $67,879.64 |
DisclosureSEC source: 0001209191-22-035221 · doc4.xml · nonDerivative · entry 1 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,494 F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| May 23, 2022 Filed May 25, 2022 20:16 UTC |
SLONIN JONATHANChief Clinical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $52.37 | $0.00 |
DisclosureSEC source: 0001209191-22-031854 · doc4.xml · derivative · entry 2 SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 Underlying: Common Stock · 2,000 shares Expires 2030-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| May 23, 2022 Filed May 25, 2022 20:16 UTC |
SLONIN JONATHANChief Clinical Officer
|
Exercise / conversionCommon Stock | 2,000 | $52.37 | $104,740.00 |
DisclosureSEC source: 0001209191-22-031854 · doc4.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 209 shares of common stock acquired under the issuer's employee stock purchase plan in December 2021. Read SEC document |
| May 09, 2022 Filed May 11, 2022 16:13 UTC |
Froimson MarkDirector
|
SaleCommon Stock | 1,000 | $59.37 | $59,370.00 |
DisclosureSEC source: 0001209191-22-028275 · doc4.xml · nonDerivative · entry 1 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,908 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.36 to $59.41, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 28, 2022 Filed May 2, 2022 18:34 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-22-026483 · doc4.xml · derivative · entry 5 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,500 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| April 28, 2022 Filed May 2, 2022 18:34 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 22,500 | $10.81 | $243,225.00 |
DisclosureSEC source: 0001209191-22-026483 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| April 21, 2022 Filed Apr 25, 2022 20:12 UTC |
REINHARDT MAXPresident, Rest of World
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $42.54 | $0.00 |
DisclosureSEC source: 0001209191-22-025516 · doc4.xml · derivative · entry 3 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 12,500 shares Expires 2029-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| April 21, 2022 Filed Apr 25, 2022 20:12 UTC |
REINHARDT MAXPresident, Rest of World
|
SaleCommon Stock | 9,824 | $73.25 | $719,647.30 |
DisclosureSEC source: 0001209191-22-025516 · doc4.xml · nonDerivative · entry 2 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,650 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · shares: Represents shares sold by the reporting person to cover the (i) exercise price of stock options and (ii) tax obligations due upon the exercise of such stock options. Read SEC document |
| April 21, 2022 Filed Apr 25, 2022 20:12 UTC |
REINHARDT MAXPresident, Rest of World
|
Exercise / conversionCommon Stock | 12,500 | $42.54 | $531,750.00 |
DisclosureSEC source: 0001209191-22-025516 · doc4.xml · nonDerivative · entry 1 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 00:25 UTC |
REINHARDT MAXPresident, Rest of World
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $42.54 | $0.00 |
DisclosureSEC source: 0001209191-22-025120 · doc4.xml · derivative · entry 9 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 12,500 shares Expires 2029-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 00:25 UTC |
REINHARDT MAXPresident, Rest of World
|
SaleCommon Stock | 9,764 | $73.99 | $722,438.36 |
DisclosureSEC source: 0001209191-22-025120 · doc4.xml · nonDerivative · entry 6 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,974 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 00:25 UTC |
REINHARDT MAXPresident, Rest of World
|
Exercise / conversionCommon Stock | 12,500 | $42.54 | $531,750.00 |
DisclosureSEC source: 0001209191-22-025120 · doc4.xml · nonDerivative · entry 5 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 00:25 UTC |
REINHARDT MAXPresident, Rest of World
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $42.54 | $0.00 |
DisclosureSEC source: 0001209191-22-025120 · doc4.xml · derivative · entry 8 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 12,500 shares Expires 2029-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 00:25 UTC |
REINHARDT MAXPresident, Rest of World
|
SaleCommon Stock | 9,321 | $72.25 | $673,442.25 |
DisclosureSEC source: 0001209191-22-025120 · doc4.xml · nonDerivative · entry 4 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,238 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · shares: Represents shares sold by the reporting person to cover the (i) exercise price of stock options and (ii) tax obligations due upon the exercise of such stock options. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.01 to $72.55, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 00:25 UTC |
REINHARDT MAXPresident, Rest of World
|
Exercise / conversionCommon Stock | 12,500 | $42.54 | $531,750.00 |
DisclosureSEC source: 0001209191-22-025120 · doc4.xml · nonDerivative · entry 3 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| April 18, 2022 Filed Apr 21, 2022 00:25 UTC |
REINHARDT MAXPresident, Rest of World
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $42.54 | $0.00 |
DisclosureSEC source: 0001209191-22-025120 · doc4.xml · derivative · entry 7 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,500 Underlying: Common Stock · 12,500 shares Expires 2029-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| April 18, 2022 Filed Apr 21, 2022 00:25 UTC |
REINHARDT MAXPresident, Rest of World
|
SaleCommon Stock | 8,941 | $73.55 | $657,610.55 |
DisclosureSEC source: 0001209191-22-025120 · doc4.xml · nonDerivative · entry 2 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,059 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · shares: Represents shares sold by the reporting person to cover the (i) exercise price of stock options and (ii) tax obligations due upon the exercise of such stock options. Read SEC document |
| April 18, 2022 Filed Apr 21, 2022 00:25 UTC |
REINHARDT MAXPresident, Rest of World
|
Exercise / conversionCommon Stock | 12,500 | $42.54 | $531,750.00 |
DisclosureSEC source: 0001209191-22-025120 · doc4.xml · nonDerivative · entry 1 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:16 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $38.35 | $0.00 |
DisclosureSEC source: 0001209191-22-023856 · doc4.xml · derivative · entry 11 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 7,000 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:16 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $34.38 | $0.00 |
DisclosureSEC source: 0001209191-22-023856 · doc4.xml · derivative · entry 10 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625 Underlying: Common Stock · 2,500 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:16 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-22-023856 · doc4.xml · derivative · entry 9 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2027-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:16 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $40.34 | $0.00 |
DisclosureSEC source: 0001209191-22-023856 · doc4.xml · derivative · entry 8 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2026-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:16 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
SaleCommon Stock | 2,503 | $77.94 | $195,083.82 |
DisclosureSEC source: 0001209191-22-023856 · doc4.xml · nonDerivative · entry 7 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,550 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.585 to $78.490, inclusive. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:16 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
SaleCommon Stock | 3,937 | $77.03 | $303,267.11 |
DisclosureSEC source: 0001209191-22-023856 · doc4.xml · nonDerivative · entry 6 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,053 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.58 to $77.57, inclusive. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:16 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
SaleCommon Stock | 16,060 | $76.03 | $1,221,041.80 |
DisclosureSEC source: 0001209191-22-023856 · doc4.xml · nonDerivative · entry 5 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,990 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.55 to $76.53, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:16 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
Exercise / conversionCommon Stock | 7,000 | $38.35 | $268,450.00 |
DisclosureSEC source: 0001209191-22-023856 · doc4.xml · nonDerivative · entry 4 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:16 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
Exercise / conversionCommon Stock | 2,500 | $34.38 | $85,937.50 |
DisclosureSEC source: 0001209191-22-023856 · doc4.xml · nonDerivative · entry 3 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:16 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
Exercise / conversionCommon Stock | 10,000 | $44.20 | $442,000.00 |
DisclosureSEC source: 0001209191-22-023856 · doc4.xml · nonDerivative · entry 2 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 20:16 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
Exercise / conversionCommon Stock | 3,000 | $40.34 | $121,020.00 |
DisclosureSEC source: 0001209191-22-023856 · doc4.xml · nonDerivative · entry 1 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 17:26 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-22-023190 · doc4.xml · derivative · entry 5 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 17:26 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 22,500 | $10.81 | $243,225.00 |
DisclosureSEC source: 0001209191-22-023190 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 20:37 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,188 | $0.00 Strike: $47.65 | $0.00 |
DisclosureSEC source: 0001209191-22-020788 · doc4.xml · derivative · entry 7 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,685 Underlying: Common Stock · 2,188 shares Expires 2030-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 20:37 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,112 | $0.00 Strike: $43.54 | $0.00 |
DisclosureSEC source: 0001209191-22-020788 · doc4.xml · derivative · entry 6 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,560 Underlying: Common Stock · 2,112 shares Expires 2029-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 20:37 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,953 | $0.00 Strike: $38.35 | $0.00 |
DisclosureSEC source: 0001209191-22-020788 · doc4.xml · derivative · entry 5 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,953 Underlying: Common Stock · 2,953 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 20:37 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
SaleCommon Stock | 7,253 | $72.67 | $527,075.51 |
DisclosureSEC source: 0001209191-22-020788 · doc4.xml · nonDerivative · entry 4 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,268 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.